Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Blog - Page 134

Blog

DARPA awarded Moderna $56 Million to enable small-scale, rapid mobile manufacturing of vaccines and therapeutics
Biotechnology | Infectious Disease | Influenza | Measles | Plague | Polio | Vaccine

DARPA awarded Moderna $56 Million to enable small-scale, rapid mobile manufacturing of vaccines and therapeutics

On Oct. 8, 2020, Moderna announced an agreement for a commitment of up to $56 million from the…

Read More DARPA awarded Moderna $56 Million to enable small-scale, rapid mobile manufacturing of vaccines and therapeuticsContinue

Yale Cancer Center received NIH grant to fund COVID-19 research in patients with hematologic cancers
COVID-19 | Life Science History | NIH

Yale Cancer Center received NIH grant to fund COVID-19 research in patients with hematologic cancers

On Oct. 8, 2020, the National Institutes of Health (NIH) awarded a Research Project Cooperative Agreement grant to…

Read More Yale Cancer Center received NIH grant to fund COVID-19 research in patients with hematologic cancersContinue

Johnson & Johnson announced EC approval of agreement to supply 200 million doses of COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Johnson & Johnson announced EC approval of agreement to supply 200 million doses of COVID-19 vaccine candidate

On Oct. 8, 2020, Johnson & Johnson announced the European Commission, acting on behalf of the European Union…

Read More Johnson & Johnson announced EC approval of agreement to supply 200 million doses of COVID-19 vaccine candidateContinue

Caladrius Biosciences opened study of CLBS119 to repair COVID-19-induced lung damage
COVID-19 | Life Science History

Caladrius Biosciences opened study of CLBS119 to repair COVID-19-induced lung damage

On Oct. 8, 2020, Caladrius Biosciences announced that it had opened its proof-of-concept study of CLBS119 as a…

Read More Caladrius Biosciences opened study of CLBS119 to repair COVID-19-induced lung damageContinue

SIGA announced Public Health Agency of Canada intent to purchase up to 33,300 courses of Oral TPOXX
Biotechnology | Infectious Disease | Therapeutics

SIGA announced Public Health Agency of Canada intent to purchase up to 33,300 courses of Oral TPOXX

On Oct. 8, 2020, SIGA Technologies announced that the Public Health Agency of Canada (PHAC) has issued an…

Read More SIGA announced Public Health Agency of Canada intent to purchase up to 33,300 courses of Oral TPOXXContinue

The Nobel Prize in Chemistry for 2020 was awarded to Emmanuelle Charpentier and Jennifer A Doudna
Biotechnology | Chemical | CRISPR | Genomics | Therapeutics

The Nobel Prize in Chemistry for 2020 was awarded to Emmanuelle Charpentier and Jennifer A Doudna

On Oct. 7, 2020, the Nobel Prize in Chemistry 2020 was awarded to Emmanuelle Charpentier and Jennifer Doudna…

Read More The Nobel Prize in Chemistry for 2020 was awarded to Emmanuelle Charpentier and Jennifer A DoudnaContinue

Abbott’s released ID NOW COVID-19 interim clinical study results to provide facts on clinical performance
Biotechnology | COVID-19 | Diagnostics | FDA

Abbott’s released ID NOW COVID-19 interim clinical study results to provide facts on clinical performance

On Oct. 7, 2020, in a continuing effort to provide the facts about ID NOW to support public…

Read More Abbott’s released ID NOW COVID-19 interim clinical study results to provide facts on clinical performanceContinue

RedHill Biopharma’s Opaganib COVID-19 study passed second independent committee review
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

RedHill Biopharma’s Opaganib COVID-19 study passed second independent committee review

On Oct. 7, 2020, RedHill Biopharma announced that the U.S. Phase 2 study with opaganib (Yeliva, ABC294640)1 in…

Read More RedHill Biopharma’s Opaganib COVID-19 study passed second independent committee reviewContinue

Rentschler Biopharma contributed to manufacturing of COVID-19 mRNA vaccine
Life Science History | Vaccine

Rentschler Biopharma contributed to manufacturing of COVID-19 mRNA vaccine

On Oct. 7, 2020, Rentschler Biopharma announced an agreement to serve as CDMO partner for BioNTech. As an…

Read More Rentschler Biopharma contributed to manufacturing of COVID-19 mRNA vaccineContinue

RedHill Biopharma opaganib COVID-19 study passed second independent committee review
COVID-19 | Therapeutics

RedHill Biopharma opaganib COVID-19 study passed second independent committee review

On Oct. 7, 2020, RedHill Biopharma announced that the U.S. Phase 2 study with opaganib (Yeliva, ABC294640)1 in…

Read More RedHill Biopharma opaganib COVID-19 study passed second independent committee reviewContinue

Sorrento announced discovery of salicyn-30 small molecule that strongly inhibits SARS-CoV-2 infection
Biotechnology | Therapeutics | Vaccine

Sorrento announced discovery of salicyn-30 small molecule that strongly inhibits SARS-CoV-2 infection

On Oct. 7, 2020, Sorrento Therapeutics announced that it had discovered a small molecule termed Salicyn-30 that demonstrated…

Read More Sorrento announced discovery of salicyn-30 small molecule that strongly inhibits SARS-CoV-2 infectionContinue

Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19
Biotechnology | COVID-19 | Therapeutics

Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19

On Oct. 7, 2020, Mateon Therapeutics announced the first patient enrolled this week in its Phase IV study…

Read More Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19Continue

Kindred Biosciences announced expansion of Manufacturing agreement with Vaxart for COVID-19 and other vaccine candidates
COVID-19 | Life Science History | Vaccine

Kindred Biosciences announced expansion of Manufacturing agreement with Vaxart for COVID-19 and other vaccine candidates

On Oct. 7, 2020, Kindred Biosciences announced it had expanded an agreement with Vaxart for the manufacture of…

Read More Kindred Biosciences announced expansion of Manufacturing agreement with Vaxart for COVID-19 and other vaccine candidatesContinue

Lilly updated progress of SARS-CoV-2 neutralizing antibody programs
COVID-19 | Life Science History

Lilly updated progress of SARS-CoV-2 neutralizing antibody programs

On Oct. 7, 2020, Eli Lilly announced additional details on its SARS-CoV-2 neutralizing antibody programs ヨ including interim…

Read More Lilly updated progress of SARS-CoV-2 neutralizing antibody programsContinue

Chemicals similar to those found in cannabis can inhibit bacterial virulence
Life Science History

Chemicals similar to those found in cannabis can inhibit bacterial virulence

On Oct. 7, 2020, UT Southwestern scientists showed that endocannabinoids, signaling molecules produced in the body that share…

Read More Chemicals similar to those found in cannabis can inhibit bacterial virulenceContinue

Sonic Healthcare enhanced test offerings with launch of multiplex assay for COVID-19 and flu
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Medical Device

Sonic Healthcare enhanced test offerings with launch of multiplex assay for COVID-19 and flu

On Oct. 7, 2020, Sonic Healthcare USA announced that it had launched a multiplex RT-PCR assay that combined…

Read More Sonic Healthcare enhanced test offerings with launch of multiplex assay for COVID-19 and fluContinue

NIH supported 85 new grants featuring high-risk, high-reward research
Life Science History | NIH

NIH supported 85 new grants featuring high-risk, high-reward research

On Oct. 6, 2020, the NIH announced it had awarded 85 grants through its High-Risk, High-Reward Research (HRHR)…

Read More NIH supported 85 new grants featuring high-risk, high-reward researchContinue

NIH RADx initiative advanced six new COVID-19 testing technologies
Biotechnology | COVID-19 | Infectious Disease | NIH | Therapeutics

NIH RADx initiative advanced six new COVID-19 testing technologies

On Oct. 6, 2020, the National Institutes of Health (NIH), working in collaboration with the Biomedical Advanced Research…

Read More NIH RADx initiative advanced six new COVID-19 testing technologiesContinue

SARS-CoV-2 may use key carbohydrate to infect cells
Life Science History | NIH

SARS-CoV-2 may use key carbohydrate to infect cells

On Oct. 6, 2020, NIH researchers announced they had found that a carbohydrate called heparan sulfate, which is…

Read More SARS-CoV-2 may use key carbohydrate to infect cellsContinue

HHS funded development of needle-free vaccine administration technology
COVID-19 | Infectious Disease | Influenza | Measles | Plague | Polio | Vaccine

HHS funded development of needle-free vaccine administration technology

On Oct. 6, 2020, the U.S. Department of Health and Human Services (HHS) announced funding of a patch…

Read More HHS funded development of needle-free vaccine administration technologyContinue

Andrea Ghez won a share of the Nobel Prize in Physics for the discovery of a supermassive compact object at the center of our galaxy (black hole).
Life Science History

Andrea Ghez won a share of the Nobel Prize in Physics for the discovery of a supermassive compact object at the center of our galaxy (black hole).

On Oct. 6, 2020, the Nobel Foundation announced that Andrea Ghez had won a share of the Nobel…

Read More Andrea Ghez won a share of the Nobel Prize in Physics for the discovery of a supermassive compact object at the center of our galaxy (black hole).Continue

FDA broadly supported Oragenicsメ pre-IND development program for its SARS-CoV-2 vaccine
FDA | Life Science History

FDA broadly supported Oragenicsメ pre-IND development program for its SARS-CoV-2 vaccine

On Oct. 6, 2020, Oragenics announced receipt of feedback to its Type B Pre-IND Meeting Request from the…

Read More FDA broadly supported Oragenicsメ pre-IND development program for its SARS-CoV-2 vaccineContinue

AIM ImmunoTech announced approval to enroll COVID-19 ‘long haulers’ in AMP-511 ME/CFS clinical trial of Ampligen
Life Science History

AIM ImmunoTech announced approval to enroll COVID-19 ‘long haulers’ in AMP-511 ME/CFS clinical trial of Ampligen

On Oct. 6, 2020, AIM ImmunoTech announced that it had received Institutional Review Board approval for the expansion…

Read More AIM ImmunoTech announced approval to enroll COVID-19 ‘long haulers’ in AMP-511 ME/CFS clinical trial of AmpligenContinue

FDA amended EUA for Hologicメs Aptima SARS-CoV-2 assay to Include COVID-19 testing of asymptomatic individuals
COVID-19 | FDA | Life Science History

FDA amended EUA for Hologicメs Aptima SARS-CoV-2 assay to Include COVID-19 testing of asymptomatic individuals

On Oct. 6, 2020, Hologic announced that its Aptimaᆴ SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA)…

Read More FDA amended EUA for Hologicメs Aptima SARS-CoV-2 assay to Include COVID-19 testing of asymptomatic individualsContinue

Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ research
Biotechnology | Diagnostics | HIV | Non-Profit Research | Therapeutics

Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ research

On Oct. 6, 2020, Hologic announced that two studies in the Journal of Clinical Microbiology demonstrated the utility…

Read More Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ researchContinue

Broad and Brigham and Women’s Hospital launched COVID-19 surveillance study
Biotechnology | COVID-19 | Medical Device

Broad and Brigham and Women’s Hospital launched COVID-19 surveillance study

On Oct. 6, 2020, clinicians and researchers from Brigham and Women’s Hospital, the Broad Institute of MIT and…

Read More Broad and Brigham and Women’s Hospital launched COVID-19 surveillance studyContinue

BioNTech and Pfizer initiated a rolling submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2
COVID-19 | Life Science History | Vaccine

BioNTech and Pfizer initiated a rolling submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2

On Oct. 6, 2020, Pfizer and BioNTech announced initiation of a rolling submission to the European Medicines Agency…

Read More BioNTech and Pfizer initiated a rolling submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2Continue

CLEAR adds LabCorp COVID-19 test results to モHealth Passヤ mobile app
COVID-19 | Life Science History

CLEAR adds LabCorp COVID-19 test results to モHealth Passヤ mobile app

On Oct. 5, 2020, CLEAR, the secure identity company, and LabCorp announced a partnership to enable users of…

Read More CLEAR adds LabCorp COVID-19 test results to モHealth Passヤ mobile appContinue

CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environments
COVID-19 | Life Science History

CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environments

On Oct. 5, 2020, CLEAR, the secure identity company, and Quest Diagnostics announced a new collaboration that aimed…

Read More CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environmentsContinue

Bristol Myers Squibb to acquire MyoKardia for $131 billion in cash
Life Science History

Bristol Myers Squibb to acquire MyoKardia for $131 billion in cash

On Oct. 5, 2020, Bristol-Myers and MyoKardia announced a definitive merger agreement under which Bristol Myers Squibb will…

Read More Bristol Myers Squibb to acquire MyoKardia for $131 billion in cashContinue

Page navigation

Previous PagePrevious 1 … 132 133 134 135 136 … 358 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search